Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 128Lymphoma 107Lymphoma, Large B-Cell, Diffuse 96Leukemia 55Burkitt Lymphoma 50Lymphoma, Non-Hodgkin 49Lymphoma, Follicular 37Lymphoma, Mantle-Cell 33Hodgkin Disease 25Retinoblastoma 16Recurrence 16Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 16Lymphoma, T-Cell, Peripheral 16Lymphoma, Large-Cell, Anaplastic 16Central Nervous System Neoplasms 16Neuroblastoma 15Lymphoma, Large-Cell, Immunoblastic 15Lymphoma, B-Cell 15Sarcoma 13Rhabdomyosarcoma 12Lymphoma, B-Cell, Marginal Zone 12Neoplasms 11Medulloblastoma 11Immunoblastic Lymphadenopathy 11Sarcoma, Ewing 10Lymphoma, T-Cell 10Leukemia, Lymphocytic, Chronic, B-Cell 9Leukemia, Biphenotypic, Acute 8Dendritic Cell Sarcoma, Interdigitating 8Enteropathy-Associated T-Cell Lymphoma 7

Interventions

deltacortene 1Vincristine 1Rituximab 1Prednisone 1Methotrexate 1Hyaluronoglucosaminidase 1Etoposide 1Doxorubicin 1Cyclophosphamide 1CT-P10 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Multi-centric Castleman's Disease × Vincristine × Clear all
NCT03864419 2024-01-03

Rituximab Hyaluronidase in Combination With Chemotherapy in Treating Aggressive B-cell Lymphoma in Uganda

Fred Hutchinson Cancer Center

Phase 1 Terminated
18 enrolled
Lymphoid

Multi-centric Castleman's Disease, Burkitt Lymphoma, Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon âš¡